Does DIO2 rs225014 CT reduce local T4-to-T3 activation and thyroid signaling?

The DIO2 gene encodes type 2 deiodinase (D2), the rate-limiting enzyme responsible for converting inactive thyroxine (T4) into biologically active triiodothyronine (T3) within target tissues.

Local thyroid signaling and genetic variation

• The DIO2 rs225014 CT (Thr/Ala heterozygous) genotype represents a partial loss-of-function state, resulting in an estimated 20% to 40% reduction in local intracellular T4-to-T3 activation compared to the wild-type CC genotype.
• This impairment is driven by reduced D2 catalytic efficiency, trans-Golgi accumulation, and endoplasmic reticulum stress, which directly limits intracellular T3 availability and blunts thyroid hormone receptor (TR) binding and local transcriptional activity.

Mitochondrial and thermogenic regulation

• Lowered intracellular thyroid signaling downregulates the transcription of Ppargc1a (PGC-1α), a master regulator of mitochondrial biogenesis.
• Decreased PGC-1α activity suppresses downstream nuclear respiratory factors (NRFs) and mitochondrial transcription factor A (TFAM), leading to diminished mitochondrial DNA replication, reduced respiratory chain capacity, and lowered mitochondrial content.
• Concurrently, reduced TRβ activation impairs the co-activation of the Ucp1 promoter by PGC-1α in brown adipose tissue, decreasing uncoupling protein 1 (UCP1) expression and lowering mitochondrial uncoupling and tissue-level thermogenesis.

Bottom line

• The DIO2 rs225014 CT genotype reduces local T4-to-T3 conversion by 20% to 40%, compromising the PGC-1α–TFAM pathway to decrease mitochondrial biogenesis and impairing TRβ-mediated UCP1 expression to lower tissue thermogenesis.